This compound is a protected nucleoside derivative used as an intermediate in the solid-phase synthesis of oligonucleotides. Its structure features a uridine base with an acetamide group and a 4,4′-dimethoxytrityl (DMT) protecting group on the 5′-hydroxyl, along with a 2′-O-methyl modification, making it suitable for RNA-based oligonucleotide assembly.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 199593-08-3
N-Acetyl-5'-O-(bis(4-methoxyphenyl)(phenyl)methyl)-2'-O-(tert-butyl(dimethyl)silyl)cytidine
nucleoside protecting group intermediate
N-Acetyl-5'-o-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroCytidine
Pharmaceutical intermediate for nucleoside synthesis
DMT-N4-Acetyl-2'-Deoxycytidine
Pharmaceutical intermediate for oligonucleotide synthesis
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
nucleoside intermediate for oligonucleotide synthesis
N-(1-((1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
nucleoside intermediate for oligonucleotide synthesis
N6-BENZOYL-2'-O-METHYL-ADENOSINE
nucleoside intermediate for oligonucleotide synthesis
1-Bromo-4-chloro-2-fluorobenzene
Pharmaceutical intermediate
4-[[[[6-[(Diethylamino)methyl]-2-naphthalenyl]methoxy]carbonyl]amino]benzoic acid
Pharmaceutical intermediate
N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
FINUHOJILDNELQ-PMFUCWTESA-N
CC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O)OC